Family Offices Gear Up for More Investments Than Ever: I Need a Weapon

Deal Making Heats Up: Ready to Rumble?

Cortana things are getting interesting. Word on the street is or rather on CNBC that family offices are ramping up their investments. After a bit of a lull they made 60 direct investments in June. That's a step up from the 47 in May. But hey even Spartans have off days right? It's still down 40% from last year. Someone needs to show these guys my Plasma Rifle. Maybe they need a little motivation like a Covenant invasion. But hey more investments mean more jobs. It's a good problem to have.

Entertainment's New Hope: Wake Me When You Need Me

Now before you start thinking these folks are all about serious business they're also having some fun. Nintendo's founding family went and bought a stake in an indie film studio called K2 Pictures. These guys are thinking outside the box. I wonder if they'll make a movie about me. I'd demand creative control. Meanwhile some billionaire named David Blitzer (never heard of him) invested in a fancy sports club. Even tennis legend Andre Agassi is in on it. Maybe I should take up padel when I’m not busy saving the galaxy. A Spartan's gotta relax somehow right?

Biotech to the Rescue: I Need a Weapon

Alright here’s where things get serious. Biotech and healthcare are the real MVPs here scoring nine deals. This company called Antheia making ingredients for Narcan (the overdose reversal med) raised a whopping $56 million. They’re using bioengineered yeast to make opioids for medical use faster. It's about damn time! This Smolke scientist sounds like she knows her stuff. She says family offices have the patience for these long term biotech projects. Which is good because these things take longer than setting up a Warthog. Glad to see people are working on this the UNSC could use some advanced medical tech out there.

The Long Game: Worth Fighting For

Smolke also mentioned that family offices can stomach longer investment horizons which aligns well with the timeline needed to bring new technology to healthcare. "These are complicated problems. There's not a sort of a quick patch that we're going to put on this," she said. "Family offices tend to be able to be patient with their investments and that aligns really well with the cycles and the timelines that are needed for biotech and to bring new products new technology and new transformation at a system level to healthcare."

Expanding Production: Let's Get to Work

Antheia's expanding from Europe to the U.S. to produce more. They're working on 70 plus ingredients for medicines to treat everything from cancer to seizures. Smolke aims to make drug shortages a thing of the past and improve global access to medicine. Now that’s an objective I can get behind. "The core aspect that's shared through all of this is being able to rebuild these essential medicine supply chains so that drug shortages become a thing of the past and access globally becomes more equitable," she said.

Impact Driven Investment: This is the Way

For family offices looking to make a real impact biotech is a good place to start. Everyone’s felt the pain of drug shortages even here in the U.S. It's about time someone did something about it. So next time you see a news story about biotech investments remember it’s not just about money. It’s about making life better for everyone. Now if you’ll excuse me I’ve got a galaxy to save. "It can speak to investors very directly," she said. "I think everybody has actually directly experienced challenges with drug shortages — even in the U.S. — of going to the supermarket and having cold medicines out of stock or not being able to get certain antibiotics."